Interest Grows in Using Psychedelic Drugs for Psychiatric Disorders

An adult psychiatry expert in the U.K. is calling for psychedelic drugs to be re-examined for their potential benefits for people with psychiatric disorders.

Dr. James Rucker of King’s College London, U.K., believes that psychedelic drugs such as lysergic acid diethylamide (LSD) “should be legally reclassified so that researchers can investigate their therapeutic potential.”

In the United States, LSD is a schedule I controlled substance under the Controlled Substances Act. This means that the federal government believes LSD to have high abuse potential, a lack of accepted safe use when taken under medical supervision, and no current medical use.

Full story of growing use of psychedelic drugs at Psych Central

Published by

Will Savage

Quantum Units Continuing Education provides online CEU training's to licensed professional mental health therapists, counselors, social workers and nurses. Our blog provides updates in the field of news and research related to mental health and substance abuse treatment.